{"id":3585,"date":"2023-02-27T15:19:01","date_gmt":"2023-02-27T14:19:01","guid":{"rendered":"https:\/\/www.access2meds.eu\/startseite\/"},"modified":"2025-06-24T10:22:49","modified_gmt":"2025-06-24T08:22:49","slug":"startseite","status":"publish","type":"page","link":"https:\/\/www.access2meds.eu\/fr\/","title":{"rendered":"Startseite"},"content":{"rendered":"<p>[et_pb_section fb_built=\u00a0\u00bb1&Prime; admin_label=\u00a0\u00bbHeader\u00a0\u00bb _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb background_image=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1217229190_Nastasic.jpg\u00a0\u00bb background_position=\u00a0\u00bbtop_center\u00a0\u00bb height=\u00a0\u00bb100vh\u00a0\u00bb max_height=\u00a0\u00bb660px\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_row _builder_version=\u00a0\u00bb4.20.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_padding=\u00a0\u00bb7px|30px||30px|false|true\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.20.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_font=\u00a0\u00bb|700|||||||\u00a0\u00bb header_line_height=\u00a0\u00bb1.1em\u00a0\u00bb custom_margin=\u00a0\u00bb11px||||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h1><span style=\"color: #e95f6c;\">AM\u00c9LIORER L&rsquo;ACC\u00c8S AUX <\/span> TECHNOLOGIES DE SANT\u00c9 INNOVANTES<br \/><\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00a0\u00bb1&Prime; admin_label=\u00a0\u00bbfirst text blue pill\u00a0\u00bb _builder_version=\u00a0\u00bb4.20.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb background_enable_color=\u00a0\u00bboff\u00a0\u00bb custom_padding=\u00a0\u00bb0px||0px||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_row custom_padding_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb module_class=\u00a0\u00bbstarttoppill\u00a0\u00bb _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb background_color=\u00a0\u00bb#3b3e84&Prime; vertical_offset=\u00a0\u00bb-90px\u00a0\u00bb max_width=\u00a0\u00bb1500px\u00a0\u00bb module_alignment=\u00a0\u00bbright\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb60px||50px|93px|false|false\u00a0\u00bb custom_padding_tablet=\u00a0\u00bb60px||50px|93px|false|false\u00a0\u00bb custom_padding_phone=\u00a0\u00bb|10px||65px|false|false\u00a0\u00bb custom_css_main_element=\u00a0\u00bbwidth:calc(100% &#8211; 125px)!important;\u00a0\u00bb border_radii=\u00a0\u00bboff|99999px|||99999px\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_css_main_element_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb custom_css_main_element_phone=\u00a0\u00bbwidth:calc(100%)!important;\u00a0\u00bb custom_css_main_element_tablet=\u00a0\u00bbwidth:calc(100% &#8211; 125px)!important;\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.20.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb text_font=\u00a0\u00bb||||||||\u00a0\u00bb text_text_color=\u00a0\u00bb#FFFFFF\u00a0\u00bb text_font_size=\u00a0\u00bb24px\u00a0\u00bb text_line_height=\u00a0\u00bb1.33em\u00a0\u00bb width=\u00a0\u00bb100%\u00a0\u00bb max_width=\u00a0\u00bb825px\u00a0\u00bb custom_margin_tablet=\u00a0\u00bb\u00a0\u00bb custom_margin_phone=\u00a0\u00bb||0px||false|false\u00a0\u00bb custom_margin_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb custom_padding_tablet=\u00a0\u00bb\u00a0\u00bb custom_padding_phone=\u00a0\u00bb||0px|10px|false|false\u00a0\u00bb custom_padding_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb text_font_size_tablet=\u00a0\u00bb22px\u00a0\u00bb text_font_size_phone=\u00a0\u00bb16px\u00a0\u00bb text_font_size_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb text_line_height_tablet=\u00a0\u00bb1.33em\u00a0\u00bb text_line_height_phone=\u00a0\u00bb1.2em\u00a0\u00bb text_line_height_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p>ASCERTAIN (Affordability and Sustainability improvements through new pricing, Cost- Effectiveness and ReimbursemenT models to Appraise INnovative health technologies) r\u00e9pond au besoin des patients, des m\u00e9decins, des payeurs, des r\u00e9gulateurs et des firmes pharmaceutiquesd\u2019am\u00e9liorer le caract\u00e8re abordable et l\u2019accessibilit\u00e9 des technologies de sant\u00e9 innovantes (y compris les produits pharmaceutiques) en Europe.<\/p>\n<p>[\/et_pb_text][et_pb_button button_url=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/fr\/impact\/\u00a0\u00bb button_text=\u00a0\u00bbD\u00e9couvrez comment vous pouvez en b\u00e9n\u00e9ficier !\u00a0\u00bb button_alignment=\u00a0\u00bbright\u00a0\u00bb module_class=\u00a0\u00bbbubble-button\u00a0\u00bb _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_button=\u00a0\u00bbon\u00a0\u00bb button_text_size=\u00a0\u00bb24px\u00a0\u00bb button_text_color=\u00a0\u00bb#FFFFFF\u00a0\u00bb button_bg_color=\u00a0\u00bbRGBA(255,255,255,0)\u00a0\u00bb button_border_width=\u00a0\u00bb0px\u00a0\u00bb button_font=\u00a0\u00bb||||||||\u00a0\u00bb button_icon=\u00a0\u00bb&#x39;||divi||400&Prime; button_on_hover=\u00a0\u00bboff\u00a0\u00bb button_text_size_tablet=\u00a0\u00bb24px\u00a0\u00bb button_text_size_phone=\u00a0\u00bb16px\u00a0\u00bb button_text_size_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb custom_css_main_element=\u00a0\u00bbfont-weight:500;\u00a0\u00bb custom_css_after=\u00a0\u00bbborder-radius: 50%;background: #e85d6b;||    width: 30px;||    height: 30px;||    text-align: center; top:10px;||    line-height: 30px !important;\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_css_after_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb custom_css_after_phone=\u00a0\u00bbborder-radius: 50%;background: #e85d6b;||    width: 20px;||    height: 20px;||    text-align: center; top:8px;||    line-height: 20px !important;\u00a0\u00bb custom_css_after_tablet=\u00a0\u00bbborder-radius: 50%;background: #e85d6b;||    width: 30px;||    height: 30px;||    text-align: center; top:10px;||    line-height: 30px !important;\u00a0\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00a0\u00bb1&Prime; admin_label=\u00a0\u00bbfaq\u00a0\u00bb module_id=\u00a0\u00bbv\u00e9rifier-faq\u00a0\u00bb _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb overflow-x=\u00a0\u00bbhidden\u00a0\u00bb custom_padding=\u00a0\u00bb0px||0px||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_row _builder_version=\u00a0\u00bb4.20.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_padding=\u00a0\u00bb0px|30px||30px|false|true\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.20.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb text_font=\u00a0\u00bb|600|||||||\u00a0\u00bb text_font_size=\u00a0\u00bb36px\u00a0\u00bb header_font=\u00a0\u00bb|600|||||||\u00a0\u00bb header_text_align=\u00a0\u00bbleft\u00a0\u00bb header_text_color=\u00a0\u00bb#FFFFFF\u00a0\u00bb header_font_size=\u00a0\u00bb36px\u00a0\u00bb header_line_height=\u00a0\u00bb75px\u00a0\u00bb background_color=\u00a0\u00bb#e85d6b\u00a0\u00bb background_image=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/fastforward.svg\u00a0\u00bb background_size=\u00a0\u00bbcustom\u00a0\u00bb background_image_width=\u00a0\u00bb31px\u00a0\u00bb background_image_height=\u00a0\u00bb30px\u00a0\u00bb background_position=\u00a0\u00bbcenter_right\u00a0\u00bb background_horizontal_offset=\u00a0\u00bb27px\u00a0\u00bb width=\u00a0\u00bb160px\u00a0\u00bb height=\u00a0\u00bb75px\u00a0\u00bb height_tablet=\u00a0\u00bb75px\u00a0\u00bb height_phone=\u00a0\u00bb50px\u00a0\u00bb height_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb custom_padding=\u00a0\u00bb|86px|||false|false\u00a0\u00bb link_option_url=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/faq\/\u00a0\u00bb header_font_size_tablet=\u00a0\u00bb36px\u00a0\u00bb header_font_size_phone=\u00a0\u00bb24px\u00a0\u00bb header_line_height_tablet=\u00a0\u00bb75px\u00a0\u00bb header_line_height_phone=\u00a0\u00bb50px\u00a0\u00bb header_line_height_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb custom_css_main_element=\u00a0\u00bboverflow:visible;\u00a0\u00bb custom_css_after=\u00a0\u00bbcontent:%22%22; display:block; width:2000px; height:100%; background:#e85d6b; position:absolute; top:0;right:160px;\u00a0\u00bb border_radii=\u00a0\u00bboff||9999px|9999px|\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h1>FAQ<\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00a0\u00bb4.20.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb background_color=\u00a0\u00bb#fbedec\u00a0\u00bb positioning=\u00a0\u00bbabsolute\u00a0\u00bb position_origin_a=\u00a0\u00bbtop_center\u00a0\u00bb vertical_offset=\u00a0\u00bb408px\u00a0\u00bb max_width=\u00a0\u00bb100%\u00a0\u00bb height=\u00a0\u00bb675px\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.20.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00a0\u00bb1_2,1_2&Prime; _builder_version=\u00a0\u00bb4.20.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_padding=\u00a0\u00bb|30px|60px|30px|false|true\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb1_2&Prime; _builder_version=\u00a0\u00bb4.20.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_blurb title=\u00a0\u00bbQu&#039;est-ce qu&#039;ASCERTAIN ?\u00a0\u00bb image=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-542576580_sturti-1024&#215;683.jpg\u00a0\u00bb image_icon_width=\u00a0\u00bb100%\u00a0\u00bb _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bb4d864e31-c790-4706-8bfe-634bfca688dd\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p>ASCERTAIN est un projet visant \u00e0 faciliter l\u2019acc\u00e8s aux nouvelles technologies de la sant\u00e9 telles que les m\u00e9dicaments, les dispositifs m\u00e9dicaux et les tests. Le projet con\u00e7oit un outil qui peut \u00eatre utilis\u00e9 par les d\u00e9cideurs pour comprendre le co\u00fbt et la valeur de ces nouvelles technologies de la sant\u00e9. <\/p>\n<p>[\/et_pb_blurb][et_pb_blurb title=\u00a0\u00bbQu&#039;est-ce que l&#039;outil de soutien politique ASCERTAIN ?\u00a0\u00bb image=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1349268982-1024&#215;683.jpg\u00a0\u00bb image_icon_width=\u00a0\u00bb100%\u00a0\u00bb _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bb4d864e31-c790-4706-8bfe-634bfca688dd\u00a0\u00bb background_color=\u00a0\u00bb#393C84&Prime; custom_margin_tablet=\u00a0\u00bb||0px||false|false\u00a0\u00bb custom_margin_phone=\u00a0\u00bb||0px||false|false\u00a0\u00bb custom_margin_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p>Cet outil en ligne sera accessible \u00e0 tous et contiendra des informations sur le co\u00fbt et la valeur de ces nouvelles technologies de la sant\u00e9. Il prendra \u00e9galement en compte l\u2019impact sur l\u2019environnement. Le projet collaborera avec les patients, l\u2019industrie, les d\u00e9cideurs politiques et les mutualit\u00e9s et assurances priv\u00e9e pour s\u2019assurer que l\u2019outil est de bonne qualit\u00e9 et utile.  <\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][et_pb_column type=\u00a0\u00bb1_2&Prime; _builder_version=\u00a0\u00bb4.20.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_css_main_element_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb custom_css_main_element_tablet=\u00a0\u00bbmargin-bottom:0 !important;\u00a0\u00bb custom_css_main_element_phone=\u00a0\u00bbmargin-bottom:0 !important;\u00a0\u00bb][et_pb_blurb title=\u00a0\u00bbPourquoi abordabilit\u00e9 des technologies de sant\u00e9 innovantes constitue-t-elle un d\u00e9fi?\u00a0\u00bb image=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1440000552-1024&#215;683.jpg\u00a0\u00bb _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bb4d864e31-c790-4706-8bfe-634bfca688dd\u00a0\u00bb background_color=\u00a0\u00bb#E85D6B\u00a0\u00bb custom_margin=\u00a0\u00bb60px||30px||false|false\u00a0\u00bb custom_margin_tablet=\u00a0\u00bb0px||30px||false|false\u00a0\u00bb custom_margin_phone=\u00a0\u00bb0px||30px||false|false\u00a0\u00bb custom_margin_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p>Pour de nombreux pays de l&rsquo;Union europ\u00e9enne, il est difficile de financer les nouvelles technologies de la sant\u00e9 parce qu&rsquo;elles sont souvent co\u00fbteuses et que tout le monde n&rsquo;y a pas acc\u00e8s de la m\u00eame mani\u00e8re. Cet outil aidera les d\u00e9cideurs \u00e0 comprendre le co\u00fbt d&rsquo;une technologie, la valeur ajout\u00e9e qu&rsquo;elle apporte aux patients et son impact potentiel sur le budget des soins de sant\u00e9. <\/p>\n<p>[\/et_pb_blurb][et_pb_blurb title=\u00a0\u00bbQuels sont les objectifs d&#039;ASCERTAIN ?\u00a0\u00bb image=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Foto_1132274611_iStock_PeopleImages-1024&#215;653.jpg\u00a0\u00bb _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bb4d864e31-c790-4706-8bfe-634bfca688dd\u00a0\u00bb background_color=\u00a0\u00bb#86B8BD\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p>L\u2019objectif d\u2019ASCERTAIN est de faciliter la compr\u00e9hension du co\u00fbt et de la valeur des nouvelles technologies de la sant\u00e9. L\u2019outil sera ouvert \u00e0 tous et pourra \u00eatre adapt\u00e9 aux besoins des diff\u00e9rents pays. Il contiendra des informations sur le co\u00fbt et l\u2019importancede ces technologies et encouragera une production plus \u00ab\u00a0verte\u00a0\u00bb.  <\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00a0\u00bb1&Prime; disabled_on=\u00a0\u00bbon|on|off\u00a0\u00bb module_id=\u00a0\u00bblangue\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb background_color=\u00a0\u00bbrgba(134,184,189,0.3)\u00a0\u00bb background_enable_image=\u00a0\u00bboff\u00a0\u00bb locked=\u00a0\u00bboff\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_row _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h3>PR\u00c9F\u00c9REZ-VOUS LIRE CETTE PAGE DANS UNE AUTRE LANGUE ?<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00a0\u00bb1_4,1_4,1_4,1_4&Prime; _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb1_4&Prime; _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_image src=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/05\/Sprechblase_Englisch-1.png\u00a0\u00bb title_text=\u00a0\u00bbSprechblase_Englisch\u00a0\u00bb url=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/fr\/\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_image][et_pb_image src=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/06\/Sprechblase_Nederlands.png\u00a0\u00bb title_text=\u00a0\u00bbSprechblase_Nederlands\u00a0\u00bb url=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/nl\/\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_image][\/et_pb_column][et_pb_column type=\u00a0\u00bb1_4&Prime; _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_image src=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/05\/Sprechblase_Deutsch.png\u00a0\u00bb title_text=\u00a0\u00bbSprechblase_Deutsch\u00a0\u00bb url=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/de\/\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_image][et_pb_image src=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/05\/Sprechblase_France.png\u00a0\u00bb title_text=\u00a0\u00bbSprechblase_France\u00a0\u00bb url=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/fr\/\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_image][\/et_pb_column][et_pb_column type=\u00a0\u00bb1_4&Prime; _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_image src=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/05\/Sprechblase_Romana.png\u00a0\u00bb title_text=\u00a0\u00bbSprechblase_Romana\u00a0\u00bb url=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/ro\/\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_image][et_pb_image src=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/06\/Sprechblase_Espanol.png\u00a0\u00bb title_text=\u00a0\u00bbSprechblase_Espanol\u00a0\u00bb url=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/es\/\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_image][\/et_pb_column][et_pb_column type=\u00a0\u00bb1_4&Prime; _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_image src=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/05\/Sprechblase_Norsk.png\u00a0\u00bb title_text=\u00a0\u00bbSprechblase_Norsk\u00a0\u00bb url=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/no\/\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_image][et_pb_image src=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/05\/Sprechblase_Hrvatski.png\u00a0\u00bb title_text=\u00a0\u00bbSprechblase_Hrvatski\u00a0\u00bb url=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/hr\/\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00a0\u00bb1&Prime; admin_label=\u00a0\u00bbevents\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_row _builder_version=\u00a0\u00bb4.20.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_padding=\u00a0\u00bb14px|30px|4px|30px|false|true\u00a0\u00bb locked=\u00a0\u00bboff\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.20.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.25.1&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb text_font=\u00a0\u00bb|600|||||||\u00a0\u00bb text_font_size=\u00a0\u00bb36px\u00a0\u00bb header_font=\u00a0\u00bb|600||on|||||\u00a0\u00bb header_text_align=\u00a0\u00bbleft\u00a0\u00bb header_text_color=\u00a0\u00bb#FFFFFF\u00a0\u00bb header_font_size=\u00a0\u00bb36px\u00a0\u00bb header_line_height=\u00a0\u00bb75px\u00a0\u00bb background_color=\u00a0\u00bb#393C84&Prime; background_image=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/fastforward.svg\u00a0\u00bb background_size=\u00a0\u00bbcustom\u00a0\u00bb background_image_width=\u00a0\u00bb31px\u00a0\u00bb background_image_height=\u00a0\u00bb30px\u00a0\u00bb background_position=\u00a0\u00bbcenter_right\u00a0\u00bb background_horizontal_offset=\u00a0\u00bb27px\u00a0\u00bb width=\u00a0\u00bb222px\u00a0\u00bb height=\u00a0\u00bb75px\u00a0\u00bb height_tablet=\u00a0\u00bb75px\u00a0\u00bb height_phone=\u00a0\u00bb50px\u00a0\u00bb height_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb custom_padding=\u00a0\u00bb|60px|||false|false\u00a0\u00bb link_option_url=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/fr\/?page_id=3423#ascertain-events\u00a0\u00bb header_font_size_tablet=\u00a0\u00bb36px\u00a0\u00bb header_font_size_phone=\u00a0\u00bb24px\u00a0\u00bb header_line_height_tablet=\u00a0\u00bb75px\u00a0\u00bb header_line_height_phone=\u00a0\u00bb50px\u00a0\u00bb header_line_height_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb custom_css_main_element=\u00a0\u00bboverflow:visible;\u00a0\u00bb custom_css_after=\u00a0\u00bbcontent:%22%22; display:block; width:2000px; height:100%; background:#393c84; position:absolute; top:0;right:222px;\u00a0\u00bb border_radii=\u00a0\u00bboff||9999px|9999px|\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h1>Events<\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00a0\u00bb4.20.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb1170px\u00a0\u00bb custom_padding=\u00a0\u00bb0px|0px||0px|false|true\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.20.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_code _builder_version=\u00a0\u00bb4.20.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<div class=\"em-view-container\" id=\"em-view-150394115\" data-view=\"list\">\r\n\t<div class=\"em-list em-events-list\" id=\"em-events-list-150394115\" data-view-id=\"150394115\">\r\n\t<div class=\"em-event em-item\" style=\"--default-border:#_CATEGORYCOLOR;\">\r\n\t<div class=\"em-meta-dates\">\r\n\t\t\t<div class=\"date\">\r\n\t\t\t\t<span class=\"day\">21 <br>-<br>21<\/span>\r\n\t\t\t\t<span class=\"month\">Oct<\/span>\r\n\t\t\t<\/div>\r\n\t<\/div>\r\n\t\r\n\t<div class=\"em-item-info\">\r\n\t\t<div class=\"em-content\">\r\n\t\t\t\r\n\t\t\r\n\t\t<h3 class=\"em-item-title\"><a href=\"https:\/\/www.access2meds.eu\/fr\/events\/ascertain-final-conference\/\">ASCERTAIN Final Conference<\/a><\/h3>\r\n\r\n\t\t<div class=\"em-item-desc\">\r\n\t\t\t<p>Join us in Brussels for our final ASCERTAIN conference.<\/p>\n\r\n\t\t\t\r\n\t\t<\/div>\r\n\t\t<\/div>\r\n\t\t<div class=\"em-item-actions input\">\r\n\t\t\t<a class=\"em-item-read-more button\" href=\"https:\/\/www.access2meds.eu\/fr\/events\/ascertain-final-conference\/\"><\/a>\r\n\t\t\t\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\t<\/div>\r\n<\/div>[\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00a0\u00bb1&Prime; admin_label=\u00a0\u00bbpartnerlogos\u00a0\u00bb module_id=\u00a0\u00bbv\u00e9rifier-nouvelles\u00a0\u00bb _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb background_color=\u00a0\u00bb#FFFFFF\u00a0\u00bb custom_padding=\u00a0\u00bb0px||0px||true|false\u00a0\u00bb locked=\u00a0\u00bboff\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_row _builder_version=\u00a0\u00bb4.20.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb positioning=\u00a0\u00bbabsolute\u00a0\u00bb position_origin_a=\u00a0\u00bbtop_center\u00a0\u00bb custom_padding=\u00a0\u00bb0px|30px|0px|30px|true|true\u00a0\u00bb locked=\u00a0\u00bboff\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.20.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.24.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb text_font=\u00a0\u00bb|600|||||||\u00a0\u00bb text_font_size=\u00a0\u00bb36px\u00a0\u00bb header_font=\u00a0\u00bb|600|||||||\u00a0\u00bb header_text_align=\u00a0\u00bbleft\u00a0\u00bb header_text_color=\u00a0\u00bb#FFFFFF\u00a0\u00bb header_font_size=\u00a0\u00bb36px\u00a0\u00bb header_line_height=\u00a0\u00bb75px\u00a0\u00bb background_color=\u00a0\u00bb#86B8BD\u00a0\u00bb background_image=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/fastforward.svg\u00a0\u00bb background_size=\u00a0\u00bbcustom\u00a0\u00bb background_image_width=\u00a0\u00bb31px\u00a0\u00bb background_image_height=\u00a0\u00bb30px\u00a0\u00bb background_position=\u00a0\u00bbcenter_right\u00a0\u00bb background_horizontal_offset=\u00a0\u00bb27px\u00a0\u00bb width=\u00a0\u00bb340px\u00a0\u00bb width_tablet=\u00a0\u00bb340px\u00a0\u00bb width_phone=\u00a0\u00bb250px\u00a0\u00bb width_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb height=\u00a0\u00bb75px\u00a0\u00bb height_tablet=\u00a0\u00bb75px\u00a0\u00bb height_phone=\u00a0\u00bb50px\u00a0\u00bb height_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb custom_padding=\u00a0\u00bb|86px|||false|false\u00a0\u00bb link_option_url=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/fr\/consortium\/\u00a0\u00bb header_font_size_tablet=\u00a0\u00bb36px\u00a0\u00bb header_font_size_phone=\u00a0\u00bb24px\u00a0\u00bb header_line_height_tablet=\u00a0\u00bb75px\u00a0\u00bb header_line_height_phone=\u00a0\u00bb50px\u00a0\u00bb header_line_height_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb custom_css_main_element=\u00a0\u00bboverflow:visible;\u00a0\u00bb custom_css_after=\u00a0\u00bbcontent:%22%22; display:block; width:2000px; height:100%; background:#048ea3; position:absolute; top:0;right:100%;\u00a0\u00bb border_radii=\u00a0\u00bboff||9999px|9999px|\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h1>VID\u00c9O<\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00a0\u00bb1&Prime; admin_label=\u00a0\u00bbnews\u00a0\u00bb module_id=\u00a0\u00bbv\u00e9rifier-nouvelles\u00a0\u00bb _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb background_color=\u00a0\u00bb#E85D6B\u00a0\u00bb custom_padding=\u00a0\u00bb0px||0px||true|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_row _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb positioning=\u00a0\u00bbabsolute\u00a0\u00bb position_origin_a=\u00a0\u00bbtop_center\u00a0\u00bb z_index=\u00a0\u00bb100&Prime; custom_padding=\u00a0\u00bb0px|30px|0px|30px|true|true\u00a0\u00bb locked=\u00a0\u00bboff\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb text_font=\u00a0\u00bb|600|||||||\u00a0\u00bb text_font_size=\u00a0\u00bb36px\u00a0\u00bb header_font=\u00a0\u00bb|600||on|||||\u00a0\u00bb header_text_align=\u00a0\u00bbleft\u00a0\u00bb header_text_color=\u00a0\u00bb#FFFFFF\u00a0\u00bb header_font_size=\u00a0\u00bb36px\u00a0\u00bb header_line_height=\u00a0\u00bb75px\u00a0\u00bb background_color=\u00a0\u00bb#048EA3&Prime; background_image=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/fastforward.svg\u00a0\u00bb background_size=\u00a0\u00bbcustom\u00a0\u00bb background_image_width=\u00a0\u00bb31px\u00a0\u00bb background_image_height=\u00a0\u00bb30px\u00a0\u00bb background_position=\u00a0\u00bbcenter_right\u00a0\u00bb background_horizontal_offset=\u00a0\u00bb27px\u00a0\u00bb width=\u00a0\u00bb190px\u00a0\u00bb height=\u00a0\u00bb75px\u00a0\u00bb height_tablet=\u00a0\u00bb75px\u00a0\u00bb height_phone=\u00a0\u00bb50px\u00a0\u00bb height_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb custom_padding=\u00a0\u00bb|60px|||false|false\u00a0\u00bb link_option_url=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/fr\/?page_id=3423&Prime; header_font_size_tablet=\u00a0\u00bb36px\u00a0\u00bb header_font_size_phone=\u00a0\u00bb24px\u00a0\u00bb header_line_height_tablet=\u00a0\u00bb75px\u00a0\u00bb header_line_height_phone=\u00a0\u00bb50px\u00a0\u00bb header_line_height_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb custom_css_main_element=\u00a0\u00bboverflow:visible;\u00a0\u00bb custom_css_after=\u00a0\u00bbcontent:%22%22; display:block; width:2000px; height:100%; background:#048ea3; position:absolute; top:0;right:100%;\u00a0\u00bb border_radii=\u00a0\u00bboff||9999px|9999px|\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h1>News<\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00a0\u00bb4.20.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb100%\u00a0\u00bb module_alignment=\u00a0\u00bbcenter\u00a0\u00bb custom_padding=\u00a0\u00bb0px|0px|0px||true|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.20.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_dp_dmb_module_205 _builder_version=\u00a0\u00bb4.20.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_padding=\u00a0\u00bb|||30px|false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_dp_dmb_module_205][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00a0\u00bb1&Prime; _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb background_enable_color=\u00a0\u00bboff\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_row _builder_version=\u00a0\u00bb4.24.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.24.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_2_font=\u00a0\u00bb|600||on|||||\u00a0\u00bb max_width=\u00a0\u00bb70%\u00a0\u00bb module_alignment=\u00a0\u00bbcenter\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb locked=\u00a0\u00bboff\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h2>regardez nos vid\u00e9os pour en savoir plus sur le projet<\/h2>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00a0\u00bb1_3,1_3,1_3&Prime; _builder_version=\u00a0\u00bb4.24.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb1_3&Prime; _builder_version=\u00a0\u00bb4.24.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_video src=\u00a0\u00bbhttps:\/\/www.youtube.com\/watch?v=JjYDG7BDNDE\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb70%\u00a0\u00bb module_alignment=\u00a0\u00bbcenter\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_video][et_pb_text _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb70%\u00a0\u00bb module_alignment=\u00a0\u00bbcenter\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb10px||10px||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p>D\u00e9couvrez la r\u00e9alisation de la s\u00e9rie en six parties \u00ab 3 Things About \u00bb (3 choses \u00e0 propos de). En six vid\u00e9os, nous visons \u00e0 vulgariser des questions complexes, en encourageant une compr\u00e9hension plus profonde des d\u00e9fis et des opportunit\u00e9s dans les sujets autour d\u2019ASCERTAIN. <\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=\u00a0\u00bb1_3&Prime; _builder_version=\u00a0\u00bb4.24.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_video src=\u00a0\u00bbhttps:\/\/www.youtube.com\/watch?v=6ZtwscRvEls\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb70%\u00a0\u00bb module_alignment=\u00a0\u00bbcenter\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_video][et_pb_text _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb70%\u00a0\u00bb module_alignment=\u00a0\u00bbcenter\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb10px||10px||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p>\u00ab\u00a03 choses sur la valeur des nouveaux m\u00e9dicaments contre le cancer\u00a0\u00bb &#8211; La sixi\u00e8me vid\u00e9o de notre s\u00e9rie ! Cette vid\u00e9o explore la mani\u00e8re dont les diff\u00e9rentes parties prenantes d\u00e9finissent la valeur des nouveaux m\u00e9dicaments anticanc\u00e9reux. <\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=\u00a0\u00bb1_3&Prime; _builder_version=\u00a0\u00bb4.24.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_video src=\u00a0\u00bbhttps:\/\/youtu.be\/xMF2ddO9abM\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb70%\u00a0\u00bb module_alignment=\u00a0\u00bbcenter\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_video][et_pb_text _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb70%\u00a0\u00bb module_alignment=\u00a0\u00bbcenter\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb10px||10px||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p>\u00ab\u00a03 choses sur le rapport co\u00fbt-efficacit\u00e9\u00a0\u00bb \u2013 La cinqui\u00e8me vid\u00e9o de notre s\u00e9rie! Cette vid\u00e9o explore l\u2019analyse de rentabilit\u00e9, une m\u00e9thode cl\u00e9 pour \u00e9valuer si les traitements sont rentables.  <\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00a0\u00bb1_3,1_3,1_3&Prime; _builder_version=\u00a0\u00bb4.24.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb1_3&Prime; _builder_version=\u00a0\u00bb4.24.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_video src=\u00a0\u00bbhttps:\/\/youtu.be\/e36OtJA90Qg\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb70%\u00a0\u00bb module_alignment=\u00a0\u00bbcenter\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_video][et_pb_text _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb70%\u00a0\u00bb module_alignment=\u00a0\u00bbcenter\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb10px||10px||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p><span>3 choses sur le remboursement\u00a0\u00bb est la quatri\u00e8me vid\u00e9o de notre s\u00e9rie. Dans cette vid\u00e9o, nous explorons les complexit\u00e9s du remboursement des m\u00e9dicaments, un facteur cl\u00e9 pour garantir l&rsquo;acc\u00e8s des patients aux nouveaux m\u00e9dicaments. <\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=\u00a0\u00bb1_3&Prime; _builder_version=\u00a0\u00bb4.24.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_video src=\u00a0\u00bbhttps:\/\/www.youtube.com\/watch?v=6ZtwscRvEls\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb70%\u00a0\u00bb module_alignment=\u00a0\u00bbcenter\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_video][et_pb_text _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb70%\u00a0\u00bb module_alignment=\u00a0\u00bbcenter\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb10px||10px||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p>\u00ab\u00a03 choses sur le prix des nouveaux m\u00e9dicaments\u00a0\u00bb \u2013 La troisi\u00e8me vid\u00e9o de notre s\u00e9rie! Dans cette vid\u00e9o, nous explorons les facteurs qui influencent le prix des m\u00e9dicaments \u2013 un sujet crucial pour l&rsquo;abordabilit\u00e9 des soins de sant\u00e9.  <\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=\u00a0\u00bb1_3&Prime; _builder_version=\u00a0\u00bb4.24.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_video src=\u00a0\u00bbhttps:\/\/www.youtube.com\/watch?v=OlmiWOpy6IA&#038;t=2s\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb70%\u00a0\u00bb module_alignment=\u00a0\u00bbcenter\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_video][et_pb_text _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb70%\u00a0\u00bb module_alignment=\u00a0\u00bbcenter\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb10px||10px||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p>\u00ab\u00a03 choses sur la tarification diff\u00e9renci\u00e9e\u00a0\u00bb \u2013 La deuxi\u00e8me vid\u00e9o de notre s\u00e9rie! Dans cette vid\u00e9o, nous analysons le concept de tarification \u00e0 niveaux multiples, une strat\u00e9gie utilis\u00e9e pour fixer des prix de m\u00e9dicaments diff\u00e9rents selon les pays et les groupes de patients. <\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00a0\u00bb1_3,1_3,1_3&Prime; _builder_version=\u00a0\u00bb4.24.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb1_3&Prime; _builder_version=\u00a0\u00bb4.24.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_video src=\u00a0\u00bbhttps:\/\/youtu.be\/8NhuaohK_Qg\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb70%\u00a0\u00bb module_alignment=\u00a0\u00bbcenter\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_video][et_pb_text _builder_version=\u00a0\u00bb4.24.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb70%\u00a0\u00bb module_alignment=\u00a0\u00bbcenter\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb10px||10px||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p>  \u00ab\u00a03 choses sur l&rsquo;acc\u00e8s au march\u00e9\u00a0\u00bb &#8211; La premi\u00e8re vid\u00e9o de notre s\u00e9rie ! Dans cette vid\u00e9o, nous nous penchons sur le concept crucial de l&rsquo;acc\u00e8s au march\u00e9, un processus essentiel pour mettre les nouveaux m\u00e9dicaments et traitements \u00e0 la disposition des patients. <\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=\u00a0\u00bb1_3&Prime; _builder_version=\u00a0\u00bb4.24.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_video src=\u00a0\u00bbhttps:\/\/www.youtube.com\/watch?v=fvjJ4-2nOxk\u00a0\u00bb _builder_version=\u00a0\u00bb4.24.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb70%\u00a0\u00bb module_alignment=\u00a0\u00bbcenter\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_video][et_pb_text _builder_version=\u00a0\u00bb4.24.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb70%\u00a0\u00bb module_alignment=\u00a0\u00bbcenter\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb10px||10px||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p><span>D\u00e9couvrez comment ASCERTAIN s&rsquo;attaque aux in\u00e9galit\u00e9s d&rsquo;acc\u00e8s aux technologies de la sant\u00e9 gr\u00e2ce \u00e0 notre derni\u00e8re vid\u00e9o d&rsquo;animation ! D\u00e9couvrez la mission du projet qui consiste \u00e0 am\u00e9liorer l&rsquo;accessibilit\u00e9 financi\u00e8re et la durabilit\u00e9 tout en promouvant l&rsquo;innovation et en tenant compte de l&rsquo;impact sur l&rsquo;environnement. <\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=\u00a0\u00bb1_3&Prime; _builder_version=\u00a0\u00bb4.24.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_video src=\u00a0\u00bbhttps:\/\/youtu.be\/sbPnTmX8Uxs\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb70%\u00a0\u00bb module_alignment=\u00a0\u00bbcenter\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_video][et_pb_text _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb70%\u00a0\u00bb module_alignment=\u00a0\u00bbcenter\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb10px||10px||false|false\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p><span>Nous sommes ravis de partager notre vid\u00e9o pr\u00e9sentant le lancement du projet ASCERTAIN \u00e0 Rotterdam ! Les membres de notre consortium se sont r\u00e9unis pour donner le coup d&rsquo;envoi de ce projet financ\u00e9 par HORIZON. <\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00a0\u00bb1&Prime; module_id=\u00a0\u00bbcontact\u00a0\u00bb _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb background_color=\u00a0\u00bb#86B8BD\u00a0\u00bb custom_margin=\u00a0\u00bb||||false|false\u00a0\u00bb custom_padding=\u00a0\u00bb16px||75px||false|false\u00a0\u00bb box_shadow_style=\u00a0\u00bbpreset7&Prime; box_shadow_horizontal=\u00a0\u00bb0px\u00a0\u00bb box_shadow_vertical=\u00a0\u00bb-274px\u00a0\u00bb box_shadow_color=\u00a0\u00bb#FFFFFF\u00a0\u00bb global_module=\u00a0\u00bb910&Prime; saved_tabs=\u00a0\u00bball\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_row _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb header_font=\u00a0\u00bbPoppins semibold|||on|||||\u00a0\u00bb header_font_size=\u00a0\u00bb36px\u00a0\u00bb custom_margin=\u00a0\u00bb14px||23px||false|false\u00a0\u00bb custom_margin_tablet=\u00a0\u00bb\u00a0\u00bb custom_margin_phone=\u00a0\u00bb||30px||false|false\u00a0\u00bb custom_margin_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb header_font_size_phone=\u00a0\u00bb24px\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h1>Contact<\/h1>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb text_font=\u00a0\u00bbPoppins regular||||||||\u00a0\u00bb text_text_color=\u00a0\u00bb#393C84&Prime; text_font_size=\u00a0\u00bb24px\u00a0\u00bb text_line_height=\u00a0\u00bb1.33em\u00a0\u00bb module_alignment=\u00a0\u00bbright\u00a0\u00bb custom_margin=\u00a0\u00bb||0px||false|false\u00a0\u00bb text_font_size_tablet=\u00a0\u00bb\u00a0\u00bb text_font_size_phone=\u00a0\u00bb18px\u00a0\u00bb text_font_size_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p>N&rsquo;h\u00e9sitez pas \u00e0 nous contacter si vous avez des questions ou des commentaires ! Nous vous r\u00e9pondrons dans les plus brefs d\u00e9lais. <\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00a0\u00bb1_3,1_3,1_3&Prime; use_custom_gutter=\u00a0\u00bbon\u00a0\u00bb module_class=\u00a0\u00bbtablet-three-cols\u00a0\u00bb _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb max_width_tablet=\u00a0\u00bb980px\u00a0\u00bb max_width_phone=\u00a0\u00bb500px\u00a0\u00bb max_width_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb custom_padding=\u00a0\u00bb0px|30px|0px|30px|false|true\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_css_main_element_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb custom_css_main_element_tablet=\u00a0\u00bbdisplay:flex;\u00a0\u00bb custom_css_main_element_phone=\u00a0\u00bbdisplay:flex; flex-direction:column;\u00a0\u00bb][et_pb_column type=\u00a0\u00bb1_3&Prime; _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbbe0fba28-f74a-4ba0-9a8d-9cd30aca805d\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_css_main_element_last_edited=\u00a0\u00bbon|tablet\u00a0\u00bb custom_css_main_element_tablet=\u00a0\u00bbmargin-bottom:0;\u00a0\u00bb custom_css_main_element_phone=\u00a0\u00bbmargin-bottom:20px;\u00a0\u00bb][et_pb_image src=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Carin_Uyl-de-Groot.png\u00a0\u00bb title_text=\u00a0\u00bbCarin_Uyl-de-Groot\u00a0\u00bb _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bba348f9e0-d57b-4c22-b522-c52b784fe57f\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_image][et_pb_text _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb text_text_color=\u00a0\u00bb#FFFFFF\u00a0\u00bb link_text_color=\u00a0\u00bb#FFFFFF\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p>Pour les questions relatives \u00e0 la recherche :<\/p>\n<p><strong>Carin Uyl-de Groot<\/strong><br \/>Coordinatrice de projet<\/p>\n<p>Universit\u00e9 Erasmus de Rotterdam<br \/><a href=\"mailto:uyl@eshpm.eur.nl\">uyl@eshpm.eur.nl<\/a><br \/>T\u00e9l\u00e9phone : +31 10 4081583<\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=\u00a0\u00bb1_3&Prime; _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbbe0fba28-f74a-4ba0-9a8d-9cd30aca805d\u00a0\u00bb background_color=\u00a0\u00bb#393C84&Prime; global_colors_info=\u00a0\u00bb{}\u00a0\u00bb custom_css_main_element_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb custom_css_main_element_tablet=\u00a0\u00bbmargin-bottom:0;\u00a0\u00bb custom_css_main_element_phone=\u00a0\u00bbmargin-bottom:20px;\u00a0\u00bb][et_pb_image src=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Marcel-Langone-1.png\u00a0\u00bb title_text=\u00a0\u00bbMarcel-Langone\u00a0\u00bb align=\u00a0\u00bbcenter\u00a0\u00bb _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bba348f9e0-d57b-4c22-b522-c52b784fe57f\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_image][et_pb_text _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb text_text_color=\u00a0\u00bb#FFFFFF\u00a0\u00bb link_text_color=\u00a0\u00bb#FFFFFF\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p>Pour des questions g\u00e9n\u00e9rales sur le projet :<\/p>\n<p><strong>Marcel Langone Marques<\/strong><br \/>Chef de projet<\/p>\n<p>Universit\u00e9 Erasmus de Rotterdam<br \/><a href=\"mailto:marcel.langonemarques@eur.nl\">marcel.langonemarques@eur.nl<\/a><br \/>T\u00e9l\u00e9phone : +31 10 4081583<\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=\u00a0\u00bb1_3&Prime; _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbbe0fba28-f74a-4ba0-9a8d-9cd30aca805d\u00a0\u00bb background_color=\u00a0\u00bb#048EA3&Prime; global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_image src=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/06\/My-project-1-7.png\u00a0\u00bb title_text=\u00a0\u00bbMon projet-1 (7)\u00a0\u00bb _builder_version=\u00a0\u00bb4.21.0&Prime; _module_preset=\u00a0\u00bba348f9e0-d57b-4c22-b522-c52b784fe57f\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_image][et_pb_text _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb text_text_color=\u00a0\u00bb#FFFFFF\u00a0\u00bb link_text_color=\u00a0\u00bb#FFFFFF\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<p>Pour les communications :<\/p>\n<p><strong>Lena Jessen<\/strong><br \/>Chef de projet<\/p>\n<p>OptiMedis<br \/><a href=\"mailto:l.jessen@optimedis.de\">l.jessen@optimedis.de<\/a><br \/>T\u00e9l\u00e9phone : +49 40 226211490<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00a0\u00bb1&Prime; admin_label=\u00a0\u00bbpartnerlogos\u00a0\u00bb module_id=\u00a0\u00bbv\u00e9rifier-nouvelles\u00a0\u00bb _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb background_color=\u00a0\u00bb#FFFFFF\u00a0\u00bb custom_padding=\u00a0\u00bb0px||0px||true|false\u00a0\u00bb locked=\u00a0\u00bboff\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_row _builder_version=\u00a0\u00bb4.20.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb positioning=\u00a0\u00bbabsolute\u00a0\u00bb position_origin_a=\u00a0\u00bbtop_center\u00a0\u00bb custom_padding=\u00a0\u00bb0px|30px|0px|30px|true|true\u00a0\u00bb locked=\u00a0\u00bboff\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.20.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb text_font=\u00a0\u00bb|600|||||||\u00a0\u00bb text_font_size=\u00a0\u00bb36px\u00a0\u00bb header_font=\u00a0\u00bb|600|||||||\u00a0\u00bb header_text_align=\u00a0\u00bbleft\u00a0\u00bb header_text_color=\u00a0\u00bb#FFFFFF\u00a0\u00bb header_font_size=\u00a0\u00bb36px\u00a0\u00bb header_line_height=\u00a0\u00bb75px\u00a0\u00bb background_color=\u00a0\u00bb#048EA3&Prime; background_image=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/fastforward.svg\u00a0\u00bb background_size=\u00a0\u00bbcustom\u00a0\u00bb background_image_width=\u00a0\u00bb31px\u00a0\u00bb background_image_height=\u00a0\u00bb30px\u00a0\u00bb background_position=\u00a0\u00bbcenter_right\u00a0\u00bb background_horizontal_offset=\u00a0\u00bb27px\u00a0\u00bb width=\u00a0\u00bb340px\u00a0\u00bb width_tablet=\u00a0\u00bb340px\u00a0\u00bb width_phone=\u00a0\u00bb250px\u00a0\u00bb width_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb height=\u00a0\u00bb75px\u00a0\u00bb height_tablet=\u00a0\u00bb75px\u00a0\u00bb height_phone=\u00a0\u00bb50px\u00a0\u00bb height_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb custom_padding=\u00a0\u00bb|86px|||false|false\u00a0\u00bb link_option_url=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/fr\/consortium\/\u00a0\u00bb header_font_size_tablet=\u00a0\u00bb36px\u00a0\u00bb header_font_size_phone=\u00a0\u00bb24px\u00a0\u00bb header_line_height_tablet=\u00a0\u00bb75px\u00a0\u00bb header_line_height_phone=\u00a0\u00bb50px\u00a0\u00bb header_line_height_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb custom_css_main_element=\u00a0\u00bboverflow:visible;\u00a0\u00bb custom_css_after=\u00a0\u00bbcontent:%22%22; display:block; width:2000px; height:100%; background:#048ea3; position:absolute; top:0;right:100%;\u00a0\u00bb border_radii=\u00a0\u00bboff||9999px|9999px|\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb]<\/p>\n<h1>Partner<\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb module_alignment=\u00a0\u00bbcenter\u00a0\u00bb custom_padding=\u00a0\u00bb90px|30px|0px|30px|false|true\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb4.20.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][et_pb_dp_oc_custom show_arrow=\u00a0\u00bboff\u00a0\u00bb show_control=\u00a0\u00bboff\u00a0\u00bb thumbnail_size=\u00a0\u00bbmedium_large\u00a0\u00bb number_thumb=\u00a0\u00bb4&Prime; number_thumb_tablet=\u00a0\u00bb4&Prime; number_thumb_phone=\u00a0\u00bb2&Prime; number_thumb_last_edited=\u00a0\u00bbon|phone\u00a0\u00bb item_margin=\u00a0\u00bb20&Prime; _builder_version=\u00a0\u00bb4.27.4&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb custom_padding=\u00a0\u00bb30px||135px||false|false\u00a0\u00bb hover_enabled=\u00a0\u00bb0&Prime; global_colors_info=\u00a0\u00bb{}\u00a0\u00bb sticky_enabled=\u00a0\u00bb0&Prime;][et_pb_dp_oc_custom_item upload_image=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Chino.io-logo-1.png\u00a0\u00bb url=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/consortium\/team-members-chino-srl\/\u00a0\u00bb admin_title=\u00a0\u00bbCINO.IO\u00a0\u00bb _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/EUR-endorsement_01_RGB_2400_colour.png\u00a0\u00bb url=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/consortium\/team-members-erasmus-universiteit-rotterdam\/\u00a0\u00bb admin_title=\u00a0\u00bbEUR\u00a0\u00bb _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/MPE-Logo-1.png\u00a0\u00bb url=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/consortium\/team-members-myeloma-patients-europe-aisbl\/\u00a0\u00bb admin_title=\u00a0\u00bbMP\u00a0\u00bb _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Comenius_University_Bratislava-1.svg\u00a0\u00bb url=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/consortium\/team-members-comenius-university-bratislava\/\u00a0\u00bb admin_title=\u00a0\u00bbCUB\u00a0\u00bb _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/R.png\u00a0\u00bb url=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/consortium\/team-members-universitetet-i-oslo\/\u00a0\u00bb admin_title=\u00a0\u00bbUiO\u00a0\u00bb _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2024\/06\/wortbildmarke-goeg-RGB.png\u00a0\u00bb url=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/consortium\/team-members-gesundheit-osterreich-gmbh\/\u00a0\u00bb admin_title=\u00a0\u00bbG\u00d6\u00a0\u00bb _builder_version=\u00a0\u00bb4.25.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2024\/08\/Logo-EHA-Black.png\u00a0\u00bb url=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/consortium\/team-members-european-hematology-association\/\u00a0\u00bb admin_title=\u00a0\u00bbEHA\u00a0\u00bb _builder_version=\u00a0\u00bb4.27.0&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/AIM-LOGO_png24-1.png\u00a0\u00bb url=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/consortium\/team-members-association-internationale-de-la-mutualite-aim\/\u00a0\u00bb admin_title=\u00a0\u00bbAIM\u00a0\u00bb _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/OptiMedis_RGB.svg\u00a0\u00bb url=\u00a0\u00bbhttps:\/\/www.access2meds.eu\/consortium\/team-members-optimedis-ag\/\u00a0\u00bb admin_title=\u00a0\u00bboptimedis\u00a0\u00bb _builder_version=\u00a0\u00bb4.20.2&Prime; _module_preset=\u00a0\u00bbdefault\u00a0\u00bb global_colors_info=\u00a0\u00bb{}\u00a0\u00bb][\/et_pb_dp_oc_custom_item][\/et_pb_dp_oc_custom][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>ASCERTAIN r\u00e9pond au besoin des patients, des m\u00e9decins, des payeurs, des r\u00e9gulateurs et des fabricants d&rsquo;am\u00e9liorer le caract\u00e8re abordable et l&rsquo;accessibilit\u00e9 des technologies de sant\u00e9 innovantes (y compris les produits pharmaceutiques) en Europe.<\/p>\n","protected":false},"author":1,"featured_media":2543,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-3585","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.8 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>ASCERTAIN - AM\u00c9LIORER L&#039;ACC\u00c8S AUX TECHNOLOGIES DE SANT\u00c9 INNOVANTES<\/title>\n<meta name=\"description\" content=\"ASCERTAIN r\u00e9pond au besoin des patients, des m\u00e9decins, des payeurs, des r\u00e9gulateurs et des fabricants d&#039;am\u00e9liorer le caract\u00e8re abordable et l&#039;accessibilit\u00e9 des technologies de sant\u00e9 innovantes (y compris les produits pharmaceutiques) en Europe.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.access2meds.eu\/fr\/startseite\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"V\u00c9RIFICATION - AM\u00c9LIORATION DE L&#039;ACC\u00c8S AUX TECHNOLOGIES DE SANT\u00c9 INNOVANTES\" \/>\n<meta property=\"og:description\" content=\"ASCERTAIN r\u00e9pond au besoin des patients, des m\u00e9decins, des payeurs, des r\u00e9gulateurs et des fabricants d&#039;am\u00e9liorer le caract\u00e8re abordable et l&#039;accessibilit\u00e9 des technologies de sant\u00e9 innovantes (y compris les produits pharmaceutiques) en Europe.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.access2meds.eu\/fr\/startseite\/\" \/>\n<meta property=\"og:site_name\" content=\"ASCERTAIN\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-24T08:22:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/Social_ASCERTAIN.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"V\u00c9RIFICATION - AM\u00c9LIORATION DE L&#039;ACC\u00c8S AUX TECHNOLOGIES DE SANT\u00c9 INNOVANTES\" \/>\n<meta name=\"twitter:description\" content=\"ASCERTAIN r\u00e9pond au besoin des patients, des m\u00e9decins, des payeurs, des r\u00e9gulateurs et des fabricants d&#039;am\u00e9liorer le caract\u00e8re abordable et l&#039;accessibilit\u00e9 des technologies de sant\u00e9 innovantes (y compris les produits pharmaceutiques) en Europe.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/Social_ASCERTAIN.png\" \/>\n<meta name=\"twitter:site\" content=\"@ASCERTAIN_EU\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"26 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/fr\\\/startseite\\\/\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/fr\\\/startseite\\\/\",\"name\":\"ASCERTAIN - AM\u00c9LIORER L'ACC\u00c8S AUX TECHNOLOGIES DE SANT\u00c9 INNOVANTES\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/fr\\\/startseite\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/fr\\\/startseite\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/iStock-1217229190_Nastasic.jpg\",\"datePublished\":\"2023-02-27T14:19:01+00:00\",\"dateModified\":\"2025-06-24T08:22:49+00:00\",\"description\":\"ASCERTAIN r\u00e9pond au besoin des patients, des m\u00e9decins, des payeurs, des r\u00e9gulateurs et des fabricants d'am\u00e9liorer le caract\u00e8re abordable et l'accessibilit\u00e9 des technologies de sant\u00e9 innovantes (y compris les produits pharmaceutiques) en Europe.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/fr\\\/startseite\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.access2meds.eu\\\/fr\\\/startseite\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/fr\\\/startseite\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/iStock-1217229190_Nastasic.jpg\",\"contentUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/iStock-1217229190_Nastasic.jpg\",\"width\":1900,\"height\":1267},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/fr\\\/startseite\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.access2meds.eu\\\/fr\\\/startseite\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Startseite\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#website\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/\",\"name\":\"ASCERTAIN\",\"description\":\"IMPROVING ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.access2meds.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\",\"name\":\"ASCERTAIN\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/ASCERTAIN-logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/ASCERTAIN-logo.svg\",\"width\":1,\"height\":1,\"caption\":\"ASCERTAIN\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/ASCERTAIN_EU\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ascertain-eu\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@ascertainproject\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ASCERTAIN - AM\u00c9LIORER L'ACC\u00c8S AUX TECHNOLOGIES DE SANT\u00c9 INNOVANTES","description":"ASCERTAIN r\u00e9pond au besoin des patients, des m\u00e9decins, des payeurs, des r\u00e9gulateurs et des fabricants d'am\u00e9liorer le caract\u00e8re abordable et l'accessibilit\u00e9 des technologies de sant\u00e9 innovantes (y compris les produits pharmaceutiques) en Europe.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.access2meds.eu\/fr\/startseite\/","og_locale":"fr_FR","og_type":"article","og_title":"V\u00c9RIFICATION - AM\u00c9LIORATION DE L'ACC\u00c8S AUX TECHNOLOGIES DE SANT\u00c9 INNOVANTES","og_description":"ASCERTAIN r\u00e9pond au besoin des patients, des m\u00e9decins, des payeurs, des r\u00e9gulateurs et des fabricants d'am\u00e9liorer le caract\u00e8re abordable et l'accessibilit\u00e9 des technologies de sant\u00e9 innovantes (y compris les produits pharmaceutiques) en Europe.","og_url":"https:\/\/www.access2meds.eu\/fr\/startseite\/","og_site_name":"ASCERTAIN","article_modified_time":"2025-06-24T08:22:49+00:00","og_image":[{"url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/Social_ASCERTAIN.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"V\u00c9RIFICATION - AM\u00c9LIORATION DE L'ACC\u00c8S AUX TECHNOLOGIES DE SANT\u00c9 INNOVANTES","twitter_description":"ASCERTAIN r\u00e9pond au besoin des patients, des m\u00e9decins, des payeurs, des r\u00e9gulateurs et des fabricants d'am\u00e9liorer le caract\u00e8re abordable et l'accessibilit\u00e9 des technologies de sant\u00e9 innovantes (y compris les produits pharmaceutiques) en Europe.","twitter_image":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/Social_ASCERTAIN.png","twitter_site":"@ASCERTAIN_EU","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"26 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.access2meds.eu\/fr\/startseite\/","url":"https:\/\/www.access2meds.eu\/fr\/startseite\/","name":"ASCERTAIN - AM\u00c9LIORER L'ACC\u00c8S AUX TECHNOLOGIES DE SANT\u00c9 INNOVANTES","isPartOf":{"@id":"https:\/\/www.access2meds.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.access2meds.eu\/fr\/startseite\/#primaryimage"},"image":{"@id":"https:\/\/www.access2meds.eu\/fr\/startseite\/#primaryimage"},"thumbnailUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1217229190_Nastasic.jpg","datePublished":"2023-02-27T14:19:01+00:00","dateModified":"2025-06-24T08:22:49+00:00","description":"ASCERTAIN r\u00e9pond au besoin des patients, des m\u00e9decins, des payeurs, des r\u00e9gulateurs et des fabricants d'am\u00e9liorer le caract\u00e8re abordable et l'accessibilit\u00e9 des technologies de sant\u00e9 innovantes (y compris les produits pharmaceutiques) en Europe.","breadcrumb":{"@id":"https:\/\/www.access2meds.eu\/fr\/startseite\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.access2meds.eu\/fr\/startseite\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.access2meds.eu\/fr\/startseite\/#primaryimage","url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1217229190_Nastasic.jpg","contentUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1217229190_Nastasic.jpg","width":1900,"height":1267},{"@type":"BreadcrumbList","@id":"https:\/\/www.access2meds.eu\/fr\/startseite\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.access2meds.eu\/fr\/startseite\/"},{"@type":"ListItem","position":2,"name":"Startseite"}]},{"@type":"WebSite","@id":"https:\/\/www.access2meds.eu\/#website","url":"https:\/\/www.access2meds.eu\/","name":"ASCERTAIN","description":"IMPROVING ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES","publisher":{"@id":"https:\/\/www.access2meds.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.access2meds.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.access2meds.eu\/#organization","name":"ASCERTAIN","url":"https:\/\/www.access2meds.eu\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.access2meds.eu\/#\/schema\/logo\/image\/","url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/02\/ASCERTAIN-logo.svg","contentUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/02\/ASCERTAIN-logo.svg","width":1,"height":1,"caption":"ASCERTAIN"},"image":{"@id":"https:\/\/www.access2meds.eu\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ASCERTAIN_EU","https:\/\/www.linkedin.com\/company\/ascertain-eu\/","https:\/\/www.youtube.com\/@ascertainproject"]}]}},"_links":{"self":[{"href":"https:\/\/www.access2meds.eu\/fr\/wp-json\/wp\/v2\/pages\/3585","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.access2meds.eu\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.access2meds.eu\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/fr\/wp-json\/wp\/v2\/comments?post=3585"}],"version-history":[{"count":10,"href":"https:\/\/www.access2meds.eu\/fr\/wp-json\/wp\/v2\/pages\/3585\/revisions"}],"predecessor-version":[{"id":4539,"href":"https:\/\/www.access2meds.eu\/fr\/wp-json\/wp\/v2\/pages\/3585\/revisions\/4539"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/fr\/wp-json\/wp\/v2\/media\/2543"}],"wp:attachment":[{"href":"https:\/\/www.access2meds.eu\/fr\/wp-json\/wp\/v2\/media?parent=3585"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}